img

Global and United States Allogeneic Stem Cell Transplantation Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Allogeneic Stem Cell Transplantation Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Allogeneic Stem Cell Transplantation Market
This report focuses on global and United States Allogeneic Stem Cell Transplantation market, also covers the segmentation data of other regions in regional level and county level.
The global Allogeneic Stem Cell Transplantation revenue was US$ 1000 million in 2022 and is forecast to a readjusted size of US$ 1503.6 million by 2033 with a CAGR of 6.0% during the review period (2023-2033).
In United States the Allogeneic Stem Cell Transplantation revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Allogeneic Stem Cell Transplantation include Mesoblast Limited, Gamida Cell Ltd., Novartis International AG, Cellectis SA, Magenta Therapeutics Inc., Fate Therapeutics Inc., Cynata Therapeutics Limited, Kiadis Pharma N.V and Takeda Pharmaceutical Company Limited, etc. The global five biggest players hold a share of % in 2022.
Global Allogeneic Stem Cell Transplantation Scope and Market Size
Allogeneic Stem Cell Transplantation market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Allogeneic Stem Cell Transplantation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Allogeneic Stem Cell Transplantation market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Mesoblast Limited
Gamida Cell Ltd.
Novartis International AG
Cellectis SA
Magenta Therapeutics Inc.
Fate Therapeutics Inc.
Cynata Therapeutics Limited
Kiadis Pharma N.V
Takeda Pharmaceutical Company Limited
JCR Pharmaceuticals Co., Ltd.
Pluristem Therapeutics Inc.
Celularity Inc.
Lineage Cell Therapeutics Inc.
Nohla Therapeutics Inc.
Orchard Therapeutics Plc
Segment by Type
Unmodified Stem Cell Transplant
T-cell Depleted Transplant
Cord Blood Transplant
Donor Lymphocyte Infusion

Segment by Application


Hospital
Ambulatory Surgical Center
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Allogeneic Stem Cell Transplantation definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Allogeneic Stem Cell Transplantation companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Allogeneic Stem Cell Transplantation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allogeneic Stem Cell Transplantation revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Allogeneic Stem Cell Transplantation Product Introduction
1.2 Global Allogeneic Stem Cell Transplantation Outlook 2018 VS 2022 VS 2033
1.2.1 Global Allogeneic Stem Cell Transplantation Market Size for the Year 2018-2033
1.2.2 United States Allogeneic Stem Cell Transplantation Market Size for the Year 2018-2033
1.3 Allogeneic Stem Cell Transplantation Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Allogeneic Stem Cell Transplantation in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Allogeneic Stem Cell Transplantation Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Allogeneic Stem Cell Transplantation Market Dynamics
1.4.1 Allogeneic Stem Cell Transplantation Industry Trends
1.4.2 Allogeneic Stem Cell Transplantation Market Drivers
1.4.3 Allogeneic Stem Cell Transplantation Market Challenges
1.4.4 Allogeneic Stem Cell Transplantation Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Allogeneic Stem Cell Transplantation by Type
2.1 Allogeneic Stem Cell Transplantation Market Segment by Type
2.1.1 Unmodified Stem Cell Transplant
2.1.2 T-cell Depleted Transplant
2.1.3 Cord Blood Transplant
2.1.4 Donor Lymphocyte Infusion
2.2 Global Allogeneic Stem Cell Transplantation Market Size by Type (2018, 2022 & 2033)
2.3 Global Allogeneic Stem Cell Transplantation Market Size by Type (2018-2033)
2.4 United States Allogeneic Stem Cell Transplantation Market Size by Type (2018, 2022 & 2033)
2.5 United States Allogeneic Stem Cell Transplantation Market Size by Type (2018-2033)
3 Allogeneic Stem Cell Transplantation by Application
3.1 Allogeneic Stem Cell Transplantation Market Segment by Application
3.1.1 Hospital
3.1.2 Ambulatory Surgical Center
3.1.3 Others
3.2 Global Allogeneic Stem Cell Transplantation Market Size by Application (2018, 2022 & 2033)
3.3 Global Allogeneic Stem Cell Transplantation Market Size by Application (2018-2033)
3.4 United States Allogeneic Stem Cell Transplantation Market Size by Application (2018, 2022 & 2033)
3.5 United States Allogeneic Stem Cell Transplantation Market Size by Application (2018-2033)
4 Global Allogeneic Stem Cell Transplantation Competitor Landscape by Company
4.1 Global Allogeneic Stem Cell Transplantation Market Size by Company
4.1.1 Global Key Companies of Allogeneic Stem Cell Transplantation, Ranked by Revenue (2022)
4.1.2 Global Allogeneic Stem Cell Transplantation Revenue by Player (2018-2023)
4.2 Global Allogeneic Stem Cell Transplantation Concentration Ratio (CR)
4.2.1 Allogeneic Stem Cell Transplantation Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Allogeneic Stem Cell Transplantation in 2022
4.2.3 Global Allogeneic Stem Cell Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Allogeneic Stem Cell Transplantation Head office and Area Served
4.4 Global Key Players of Allogeneic Stem Cell Transplantation, Product and Application
4.5 Global Key Players of Allogeneic Stem Cell Transplantation, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Allogeneic Stem Cell Transplantation Market Size by Company
4.7.1 Key Players of Allogeneic Stem Cell Transplantation in United States, Ranked by Revenue (2022)
4.7.2 United States Allogeneic Stem Cell Transplantation Revenue by Players (2021, 2022 & 2023)
5 Global Allogeneic Stem Cell Transplantation Market Size by Region
5.1 Global Allogeneic Stem Cell Transplantation Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Allogeneic Stem Cell Transplantation Market Size by Region (2018-2033)
5.2.1 Global Allogeneic Stem Cell Transplantation Market Size by Region: 2018-2023
5.2.2 Global Allogeneic Stem Cell Transplantation Market Size by Region (2024-2033)
6 Americas
6.1 Americas Allogeneic Stem Cell Transplantation Market Size YoY Growth 2018-2033
6.2 Americas Allogeneic Stem Cell Transplantation Market Size by Type
6.2.1 Americas Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023)
6.2.2 Americas Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033)
6.2.3 Americas Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
6.3 Americas Allogeneic Stem Cell Transplantation Market Size by Application
6.3.1 Americas Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023)
6.3.2 Americas Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033)
6.3.3 Americas Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
6.4 Americas Allogeneic Stem Cell Transplantation Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Allogeneic Stem Cell Transplantation Market Size YoY Growth 2018-2033
7.2 EMEA Allogeneic Stem Cell Transplantation Market Size by Type
7.2.1 EMEA Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023)
7.2.2 EMEA Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033)
7.2.3 EMEA Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
7.3 EMEA Allogeneic Stem Cell Transplantation Market Size by Application
7.3.1 EMEA Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023)
7.3.2 EMEA Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033)
7.3.3 EMEA Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
7.4 EMEA Allogeneic Stem Cell Transplantation Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Allogeneic Stem Cell Transplantation Market Size YoY Growth 2018-2033
8.2 China Allogeneic Stem Cell Transplantation Market Size by Type
8.2.1 China Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023)
8.2.2 China Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033)
8.2.3 China Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
8.3 China Allogeneic Stem Cell Transplantation Market Size by Application
8.3.1 China Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023)
8.3.2 China Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033)
8.3.3 China Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Allogeneic Stem Cell Transplantation Market Size YoY Growth 2018-2033
9.2 APAC Allogeneic Stem Cell Transplantation Market Size by Type
9.2.1 APAC Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023)
9.2.2 APAC Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033)
9.2.3 APAC Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
9.3 APAC Allogeneic Stem Cell Transplantation Market Size by Application
9.3.1 APAC Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023)
9.3.2 APAC Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033)
9.3.3 APAC Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
9.4 APAC Allogeneic Stem Cell Transplantation Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Mesoblast Limited
10.1.1 Mesoblast Limited Company Details
10.1.2 Mesoblast Limited Business Overview
10.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Introduction
10.1.4 Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.1.5 Mesoblast Limited Recent Development
10.2 Gamida Cell Ltd.
10.2.1 Gamida Cell Ltd. Company Details
10.2.2 Gamida Cell Ltd. Business Overview
10.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Introduction
10.2.4 Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.2.5 Gamida Cell Ltd. Recent Development
10.3 Novartis International AG
10.3.1 Novartis International AG Company Details
10.3.2 Novartis International AG Business Overview
10.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Introduction
10.3.4 Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.3.5 Novartis International AG Recent Development
10.4 Cellectis SA
10.4.1 Cellectis SA Company Details
10.4.2 Cellectis SA Business Overview
10.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Introduction
10.4.4 Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.4.5 Cellectis SA Recent Development
10.5 Magenta Therapeutics Inc.
10.5.1 Magenta Therapeutics Inc. Company Details
10.5.2 Magenta Therapeutics Inc. Business Overview
10.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
10.5.4 Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.5.5 Magenta Therapeutics Inc. Recent Development
10.6 Fate Therapeutics Inc.
10.6.1 Fate Therapeutics Inc. Company Details
10.6.2 Fate Therapeutics Inc. Business Overview
10.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
10.6.4 Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.6.5 Fate Therapeutics Inc. Recent Development
10.7 Cynata Therapeutics Limited
10.7.1 Cynata Therapeutics Limited Company Details
10.7.2 Cynata Therapeutics Limited Business Overview
10.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Introduction
10.7.4 Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.7.5 Cynata Therapeutics Limited Recent Development
10.8 Kiadis Pharma N.V
10.8.1 Kiadis Pharma N.V Company Details
10.8.2 Kiadis Pharma N.V Business Overview
10.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Introduction
10.8.4 Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.8.5 Kiadis Pharma N.V Recent Development
10.9 Takeda Pharmaceutical Company Limited
10.9.1 Takeda Pharmaceutical Company Limited Company Details
10.9.2 Takeda Pharmaceutical Company Limited Business Overview
10.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Introduction
10.9.4 Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.9.5 Takeda Pharmaceutical Company Limited Recent Development
10.10 JCR Pharmaceuticals Co., Ltd.
10.10.1 JCR Pharmaceuticals Co., Ltd. Company Details
10.10.2 JCR Pharmaceuticals Co., Ltd. Business Overview
10.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Introduction
10.10.4 JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.10.5 JCR Pharmaceuticals Co., Ltd. Recent Development
10.11 Pluristem Therapeutics Inc.
10.11.1 Pluristem Therapeutics Inc. Company Details
10.11.2 Pluristem Therapeutics Inc. Business Overview
10.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
10.11.4 Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.11.5 Pluristem Therapeutics Inc. Recent Development
10.12 Celularity Inc.
10.12.1 Celularity Inc. Company Details
10.12.2 Celularity Inc. Business Overview
10.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Introduction
10.12.4 Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.12.5 Celularity Inc. Recent Development
10.13 Lineage Cell Therapeutics Inc.
10.13.1 Lineage Cell Therapeutics Inc. Company Details
10.13.2 Lineage Cell Therapeutics Inc. Business Overview
10.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
10.13.4 Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.13.5 Lineage Cell Therapeutics Inc. Recent Development
10.14 Nohla Therapeutics Inc.
10.14.1 Nohla Therapeutics Inc. Company Details
10.14.2 Nohla Therapeutics Inc. Business Overview
10.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
10.14.4 Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.14.5 Nohla Therapeutics Inc. Recent Development
10.15 Orchard Therapeutics Plc
10.15.1 Orchard Therapeutics Plc Company Details
10.15.2 Orchard Therapeutics Plc Business Overview
10.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Introduction
10.15.4 Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
10.15.5 Orchard Therapeutics Plc Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Allogeneic Stem Cell Transplantation Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Allogeneic Stem Cell Transplantation Market Trends
Table 3. Allogeneic Stem Cell Transplantation Market Drivers
Table 4. Allogeneic Stem Cell Transplantation Market Challenges
Table 5. Allogeneic Stem Cell Transplantation Market Restraints
Table 6. Global Allogeneic Stem Cell Transplantation Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Allogeneic Stem Cell Transplantation Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Allogeneic Stem Cell Transplantation Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Allogeneic Stem Cell Transplantation Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Allogeneic Stem Cell Transplantation, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Allogeneic Stem Cell Transplantation Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Allogeneic Stem Cell Transplantation Revenue Share by Player, 2018-2023
Table 13. Global Allogeneic Stem Cell Transplantation Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Allogeneic Stem Cell Transplantation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2022)
Table 15. Global Key Players of Allogeneic Stem Cell Transplantation, Headquarters and Area Served
Table 16. Global Key Players of Allogeneic Stem Cell Transplantation, Product and Application
Table 17. Global Key Players of Allogeneic Stem Cell Transplantation, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Allogeneic Stem Cell Transplantation in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Allogeneic Stem Cell Transplantation Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Allogeneic Stem Cell Transplantation Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Allogeneic Stem Cell Transplantation Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Allogeneic Stem Cell Transplantation Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Allogeneic Stem Cell Transplantation Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Allogeneic Stem Cell Transplantation Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Allogeneic Stem Cell Transplantation Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Allogeneic Stem Cell Transplantation Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Allogeneic Stem Cell Transplantation Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Allogeneic Stem Cell Transplantation Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Allogeneic Stem Cell Transplantation Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Allogeneic Stem Cell Transplantation Market Size by Region (2024-2033) & (US$ Million)
Table 51. Mesoblast Limited Company Details
Table 52. Mesoblast Limited Business Overview
Table 53. Mesoblast Limited Allogeneic Stem Cell Transplantation Product
Table 54. Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 55. Mesoblast Limited Recent Development
Table 56. Gamida Cell Ltd. Company Details
Table 57. Gamida Cell Ltd. Business Overview
Table 58. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product
Table 59. Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 60. Gamida Cell Ltd. Recent Development
Table 61. Novartis International AG Company Details
Table 62. Novartis International AG Business Overview
Table 63. Novartis International AG Allogeneic Stem Cell Transplantation Product
Table 64. Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 65. Novartis International AG Recent Development
Table 66. Cellectis SA Company Details
Table 67. Cellectis SA Business Overview
Table 68. Cellectis SA Allogeneic Stem Cell Transplantation Product
Table 69. Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 70. Cellectis SA Recent Development
Table 71. Magenta Therapeutics Inc. Company Details
Table 72. Magenta Therapeutics Inc. Business Overview
Table 73. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 74. Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 75. Magenta Therapeutics Inc. Recent Development
Table 76. Fate Therapeutics Inc. Company Details
Table 77. Fate Therapeutics Inc. Business Overview
Table 78. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 79. Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 80. Fate Therapeutics Inc. Recent Development
Table 81. Cynata Therapeutics Limited Company Details
Table 82. Cynata Therapeutics Limited Business Overview
Table 83. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product
Table 84. Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 85. Cynata Therapeutics Limited Recent Development
Table 86. Kiadis Pharma N.V Company Details
Table 87. Kiadis Pharma N.V Business Overview
Table 88. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product
Table 89. Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 90. Kiadis Pharma N.V Recent Development
Table 91. Takeda Pharmaceutical Company Limited Company Details
Table 92. Takeda Pharmaceutical Company Limited Business Overview
Table 93. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product
Table 94. Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 95. Takeda Pharmaceutical Company Limited Recent Development
Table 96. JCR Pharmaceuticals Co., Ltd. Company Details
Table 97. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 98. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product
Table 99. JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 100. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 101. Pluristem Therapeutics Inc. Company Details
Table 102. Pluristem Therapeutics Inc. Business Overview
Table 103. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 104. Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 105. Pluristem Therapeutics Inc. Recent Development
Table 106. Celularity Inc. Company Details
Table 107. Celularity Inc. Business Overview
Table 108. Celularity Inc. Allogeneic Stem Cell Transplantation Product
Table 109. Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 110. Celularity Inc. Recent Development
Table 111. Lineage Cell Therapeutics Inc. Company Details
Table 112. Lineage Cell Therapeutics Inc. Business Overview
Table 113. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 114. Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 115. Lineage Cell Therapeutics Inc. Recent Development
Table 116. Nohla Therapeutics Inc. Company Details
Table 117. Nohla Therapeutics Inc. Business Overview
Table 118. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 119. Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 120. Nohla Therapeutics Inc. Recent Development
Table 121. Orchard Therapeutics Plc Company Details
Table 122. Orchard Therapeutics Plc Business Overview
Table 123. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product
Table 124. Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 125. Orchard Therapeutics Plc Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Allogeneic Stem Cell Transplantation Product Picture
Figure 2. Global Allogeneic Stem Cell Transplantation Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Allogeneic Stem Cell Transplantation Market Size 2018-2033 (US$ Million)
Figure 4. United States Allogeneic Stem Cell Transplantation Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Allogeneic Stem Cell Transplantation Market Size 2018-2033 (US$ Million)
Figure 6. United States Allogeneic Stem Cell Transplantation Market Share in Global 2018-2033
Figure 7. Allogeneic Stem Cell Transplantation Report Years Considered
Figure 8. Product Picture of Unmodified Stem Cell Transplant
Figure 9. Product Picture of T-cell Depleted Transplant
Figure 10. Product Picture of Cord Blood Transplant
Figure 11. Product Picture of Donor Lymphocyte Infusion
Figure 12. Global Allogeneic Stem Cell Transplantation Market Share by Type in 2022 & 2033
Figure 13. Global Allogeneic Stem Cell Transplantation Market Size by Type (2018-2033) & (US$ Million)
Figure 14. Global Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
Figure 15. United States Allogeneic Stem Cell Transplantation Market Share by Type in 2022 & 2033
Figure 16. United States Allogeneic Stem Cell Transplantation Market Size by Type (2018-2033) & (US$ Million)
Figure 17. United States Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Ambulatory Surgical Center
Figure 20. Product Picture of Others
Figure 21. Global Allogeneic Stem Cell Transplantation Market Share by Application in 2022 & 2033
Figure 22. Global Allogeneic Stem Cell Transplantation Market Size by Application (2018-2033) & (US$ Million)
Figure 23. Global Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
Figure 24. United States Allogeneic Stem Cell Transplantation Market Share by Application in 2022 & 2033
Figure 25. United States Allogeneic Stem Cell Transplantation Market Size by Application (2018-2033) & (US$ Million)
Figure 26. United States Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
Figure 27. The Top 5 and 10 Largest Companies of Allogeneic Stem Cell Transplantation in the World: Market Share by Allogeneic Stem Cell Transplantation Revenue in 2022
Figure 28. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 29. Global Allogeneic Stem Cell Transplantation Market Share by Region (2018-2033)
Figure 30. Americas Allogeneic Stem Cell Transplantation Market Size Growth Rate 2018-2033 (US$ Million)
Figure 31. Americas Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
Figure 32. Americas Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
Figure 33. United States Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Canada Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Mexico Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Brazil Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. EMEA Allogeneic Stem Cell Transplantation Market Size Growth Rate 2018-2033 (US$ Million)
Figure 38. EMEA Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
Figure 39. EMEA Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
Figure 40. Europe Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Middle East Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Africa Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Allogeneic Stem Cell Transplantation Market Size Growth Rate 2018-2033 (US$ Million)
Figure 44. China Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
Figure 45. China Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
Figure 46. APAC Allogeneic Stem Cell Transplantation Market Size Growth Rate 2018-2033 (US$ Million)
Figure 47. APAC Allogeneic Stem Cell Transplantation Market Share by Type (2018-2033)
Figure 48. APAC Allogeneic Stem Cell Transplantation Market Share by Application (2018-2033)
Figure 49. Japan Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. South Korea Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. China Taiwan Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. India Allogeneic Stem Cell Transplantation Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. Mesoblast Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 55. Gamida Cell Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 56. Novartis International AG Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 57. Cellectis SA Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 58. Magenta Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 59. Fate Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 60. Cynata Therapeutics Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 61. Kiadis Pharma N.V Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 62. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 63. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 64. Pluristem Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 65. Celularity Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 66. Lineage Cell Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 67. Nohla Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 68. Orchard Therapeutics Plc Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed